Attorney Robert Rush joins Joe in Breckenridge to talk about challenging DEA scheduling decisions, from the 2024 DOI and DOC hearing to the emergency scheduling of 7-OH compounds and SR-17018. They also look at what FDA approval of MDMA and psilocybin could mean if only the pharmaceutical versions get rescheduled.
Psychedelics TodayNovember 5, 20261 min read
Curated by Paradise Farmers Market
Read the full story
Continue reading at Psychedelics Today
Originally reported by Psychedelics Today at Psychedelics Today
Paradise Farmers Market curates content for educational purposes.
